Workflow
Actelis(ASNS) - Prospectus
2025-12-02 21:17
As filed with the United States Securities and Exchange Commission on December 2, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Actelis Networks, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) Delaware 3669 52-2160309 (I.R.S. Employer Identification Number) Ac ...
Nuobikan Artificial Intelligence Technology (Chengdu) Co., Ltd.(02635) - PHIP (1st submission)
2025-12-02 16:00
The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Post Hearing Information Pack, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Post Hearing Information Pack. Post Hearing Information Pack of Nuobikan Artificial Intelligence Technology (Chengdu) Co., Ltd. 諾比侃人工智能科技 (成 都 ...
Genor Biopharma Holdings Limited(H0199) - PHIP (1st submission)
2025-12-02 16:00
The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Post Hearing Information Pack, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Post Hearing Information Pack. Post Hearing Information Pack of GENOR BIOPHARMA HOLDINGS LIMITED 嘉和生物藥業 (開 曼 )控股有限公司 (the "Company") (Incorpora ...
Unisplendour Corporation Limited(H0192) - Application Proof (1st submission)
2025-12-02 16:00
The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of Unisplendour Corporation Limited 紫光股份有限公司 (the "Company") (A joint stock limited company incorporated in the People ...
WUS Printed Circuit (Kunshan) Co., Ltd.(H0191) - OC Announcement - Appointment (Revised)
2025-12-02 16:00
The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. WUS PRINTED CIRCUIT (KUNSHAN) CO., LTD. 滬士電子股份有限公司 (A joint stock company incorporated in the People's Republic of China with limited liability) W ...
Unisplendour Corporation Limited(H0192) - OC Announcement - Appointment
2025-12-02 16:00
The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. Unisplendour Corporation Limited 紫光股份有限公司 No offer or invitation will be made to the public in Hong Kong until after a prospectus of the Company h ...
Hanx Biopharmaceuticals (Wuhan) Co., Ltd. - B(03378) - PHIP (1st submission)
2025-12-02 16:00
The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Post Hearing Information Pack, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Post Hearing Information Pack. Post Hearing Information Pack of Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (翰思艾泰生物醫藥科技 (武 漢 )股份有限公司 ) (the "Comp ...
Shenzhen CVA Innovation Co., Ltd.(H0193) - Application Proof (1st submission)
2025-12-02 16:00
The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of SHENZHEN CVA INNOVATION CO., LTD.* 深圳曦華科技股份有限公司 (A joint stock company incorporated in the People's Republic of Chi ...
Shenzhen CVA Innovation Co., Ltd.(H0193) - OC Announcement - Appointment
2025-12-02 16:00
SHENZHEN CVA INNOVATION CO., LTD.* 深圳曦華科技股份有限公司 (A joint stock company incorporated in the People's Republic of China with limited liability) WARNING The publication of this announcement is required by The Stock Exchange of Hong Kong Limited (the "Stock Exchange") and the Securities and Futures Commission (the "Commission") solely for the purpose of providing information to the public in Hong Kong. By viewing this announcement, you acknowledge, accept and agree with Shenzhen CVA Innovation Co., Ltd.* (深圳曦華科 ...
Hanx Biopharmaceuticals (Wuhan) Co., Ltd. - B(03378) - Application Proof (1st submission)
2025-12-02 16:00
WARNING The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (翰思艾泰生物醫藥科技(武漢)股份有限公司 ) (the "Company") (A joint stock company in ...